— Know what they know.
Not Investment Advice

SURF NASDAQ

Surface Oncology, Inc.
1W: +5.9% 1M: +11.5% 3M: +39.5% 1Y: -21.9% 3Y: -83.9% 5Y: -89.6%
$1.07
Last traded 2023-09-12 — delisted
NASDAQ · Healthcare · Biotechnology · $65.1M mcap · 49M float · 0.801% daily turnover

Balance Sheet Trends

Total Assets
$160M -16.2% ▼
5Y CAGR: +14.4%
Total Liabilities
$67M -7.6% ▼
5Y CAGR: -7.9%
Shareholders Equity
$93M -21.4% ▼
Cash & Investments
$125M -19.0% ▼
5Y CAGR: +14.5%
Total Debt
$56M -2.2% ▼
Net Debt
$5M +305.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$159M$47M$175M$56M$51M
Short-Term Investments$0$58M$0$98M$74M
Cash & ST Investments$159M$105M$175M$154M$125M
Net Receivables$0$0$0$0$0
Inventory$0-$336K$0-$765K-$197K
Other Current Assets$6M$3M$5M$3M$4M
Total Current Assets$165M$108M$181M$157M$129M
Property, Plant & Equip.$8M$22M$35M$32M$29M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$1M$2M$2M$2M$2M
Total Non-Current Assets$9M$24M$37M$34M$31M
Total Assets$174M$132M$217M$191M$160M
— Liabilities —
Accounts Payable$3M$3M$2M$2M$256K
Short-Term Debt$0$3M$6M$5M$6M
Deferred Revenue$54M$39M$9M$10M$0
Other Current Liabilities$9M$8M$10M$13M$10M
Total Current Liabilities$27M$19M$18M$20M$16M
Long-Term Debt$0$22M$44M$52M$50M
Other Non-Current Liab.$5M$0$0$0$0
Total Non-Current Liabilities$44M$56M$44M$52M$50M
Total Liabilities$71M$75M$61M$72M$67M
— Equity —
Common Stock$3K$3K$4K$5K$6K
Retained Earnings-$67M-$122M-$62M-$141M-$204M
Accumulated OCI-$119K$103K$0-$221K-$1M
Total Stockholders Equity$103M$57M$156M$119M$93M
Total Liabilities & Equity$174M$132M$217M$191M$160M
— Key Metrics —
Total Debt$0$25M$49M$57M$56M
Net Debt-$159M-$22M-$126M$1M$5M
Total Investments$0$58M$0$98M$74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms